Secret of the major birch pollen allergen Bet v 1: identification of the physiological ligand

被引:77
|
作者
Seutter von Loetzen, Christian [1 ,2 ]
Hoffmann, Thomas [3 ]
Hartl, Maximilian J. [1 ,2 ]
Schweimer, Kristian [1 ,2 ]
Schwab, Wilfried [3 ]
Roesch, Paul [1 ,2 ]
Hartl-Spiegelhauer, Olivia [1 ,2 ]
机构
[1] Univ Bayreuth, Lehrstuhl Biopolymere, D-95447 Bayreuth, Germany
[2] Univ Bayreuth, Forschungszentrum Biomakromol, D-95447 Bayreuth, Germany
[3] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany
关键词
allergen; Bet v 1; NMR; quercetin-3-O-sophoroside (Q3OS); PATHOGENESIS-RELATED PROTEINS; LECTIN-CARBOHYDRATE INTERACTIONS; FLAVONOL; 3-O-GALACTOSYLTRANSFERASE; BIOLOGICAL FUNCTION; CROSS-REACTIVITY; IGE REACTIVITY; FOOD ALLERGENS; IN-VITRO; X-RAY; BET-V-1;
D O I
10.1042/BJ20130413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The major birch pollen allergen Bet v 1 is the main elicitor of airborne type I allergies and belongs to the PR-10 family (pathogenesis-related proteins 10). Bet v 1 is the most extensively studied allergen, and is well characterized at a biochemical and immunological level; however, its physiological function remains elusive. In the present study, we identify Q3OS (quercetin-3-O-sophoroside) as the natural ligand of Bet v 1. We isolated Q3OS bound to Bet v 1 from mature birch pollen and confirmed its binding by reconstitution of the Bet v 1-Q3OS complex. Fluorescence and UV visible spectroscopy experiments, as well as HSQC (heteronuclear single-quantum coherence) titration, and the comparison with model compounds, such as quercetin, indicated the specificity of Q3OS binding. Elucidation of the binding site by NMR combined with a computational model resulted in a more detailed understanding and shed light on the physiological function of Bet v 1. We postulate that the binding of Q3OS to Bet v 1 plays an important, but as yet unclear, role during the inflammation response and Bet v 1 recognition by IgE.
引用
收藏
页码:379 / 390
页数:12
相关论文
共 50 条
  • [1] Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 is Isoform Dependent
    von Loetzen, Christian Seutter
    Jacob, Thessa
    Hartl-Spiegelhauer, Olivia
    Vogel, Lothar
    Schiller, Dirk
    Spoerlein-Guettler, Cornelia
    Schobert, Rainer
    Vieths, Stefan
    Hartl, Maximilian Johannes
    Roesch, Paul
    PLOS ONE, 2015, 10 (06):
  • [2] Bioavailability of the major birch pollen allergen Bet v 1
    Ochs, S
    Wallmuth, A
    Kasche, A
    Weichenmeier, I
    Traidl-Hoffmann, C
    Huss-Marp, J
    Krämer, U
    Link, E
    Gebauer, G
    Schober, W
    Behrendt, H
    Buters, JTM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 134 - 134
  • [3] Ligand binding influences the physicochemical properties of the major birch pollen allergen Bet v 1
    Aglas, L.
    Asam, C.
    Gilles, S.
    Traidl-Hoffmann, C.
    Ferreira, F.
    Wallner, M.
    ALLERGY, 2015, 70 : 560 - 560
  • [4] The History and Science of the Major Birch Pollen Allergen Bet v 1
    Breiteneder, Heimo
    Kraft, Dietrich
    BIOMOLECULES, 2023, 13 (07)
  • [5] The major birch pollen allergen, Bet v 1, shows ribonuclease activity
    Bufe, A
    Spangfort, MD
    Kahlert, H
    Schlaak, M
    Becker, WM
    PLANTA, 1996, 199 (03) : 413 - 415
  • [6] Dynamics Rationalize Proteolytic Susceptibility of the Major Birch Pollen Allergen Bet v 1
    Kamenik, Anna S.
    Hofer, Florian
    Handle, Philip H.
    Liedl, Klaus R.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [7] Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1
    Vrtala, S
    Hirtenlehner, K
    Susani, M
    Akdis, M
    Kussebi, F
    Akdis, CA
    Blaser, K
    Hufnagl, P
    Binder, BR
    Politou, A
    Pastore, A
    Vangelista, L
    Sperr, WR
    Semper, H
    Valent, P
    Ebner, C
    Kraft, D
    Valenta, R
    FASEB JOURNAL, 2001, 15 (09): : 2045 - +
  • [8] The major birch pollen allergen Bet v 1 binds lipids from birch and grass pollen but not from peanuts
    Gepp, B.
    Ackerbauer, D.
    Lengger, N.
    Gruber, F.
    Mildner, M.
    Breiteneder, H.
    ALLERGY, 2014, 69 : 464 - 464
  • [10] Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
    Mahler, V
    Vrtala, S
    Kuss, O
    Diepgen, TL
    Suck, R
    Cromwell, O
    Fiebig, H
    Hartl, A
    Thalhamer, J
    Schuler, G
    Kraft, D
    Valenta, R
    CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (01): : 115 - 122